Vimarsana
Biggest News Aggregation in the World

Transfusion Burden News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Transfusion Burden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Transfusion Burden Today - Breaking & Trending Today

FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower Risk Transfusion-Dependent Myelodysplastic Syndromes at American Society of Hematology Annual Meeting - Vimarsana News

FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower Risk Transfusion-Dependent Myelodysplastic Syndromes at American Society of Hematology Annual Meeting

A post hoc analysis of patients with higher transfusion burden at baseline showed a larger percentage of patients achieved transfusion independence ≥ 56 days with roxadustat vs. placebo . Dr. Moshe...

Growth Factor and Stem Cell Transplant Candidacy in MDS - Vimarsana News

Growth Factor and Stem Cell Transplant Candidacy in MDS

Considerations for growth factor and stem cell transplant for patients with MDS is discussed.

Source: ajmc.com
Examining Treatment Algorithms for MDS - Vimarsana News

Examining Treatment Algorithms for MDS

Dr Haumschild leads a discussion surrounding the latest advancements in treatment algorithms for myelodysplastic syndrome.

Source: ajmc.com
MDS-Related Complications Impacting Patient Quality of Life - Vimarsana News

MDS-Related Complications Impacting Patient Quality of Life

Key opinion leaders discuss how patient quality of life is impacted by MDS treatment-associated challenges.

Source: ajmc.com
Economic Implications of MDS Management - Vimarsana News

Economic Implications of MDS Management

Financial considerations in MDS treatment are discussed.

Source: ajmc.com